It is concluded that mislocalization of AQP4 from perivascular end-feet to the cell body in reactive astrocytes is associated with the reduction of efficacy of the glymphatic system and the onset of pathological cerebral findings following AD, TBI, and stroke (Figure 2). The gene discussed is AQP4; the disease is Alzheimer disease.